Effectiveness of Nirsevimab Immunoprophylaxis Administered at Birth to Prevent Infant Hospitalisation for Respiratory Syncytial Virus Infection: A Population-Based Cohort Study.
- Resource Type
- Article
- Source
- Vaccines; Apr2024, Vol. 12 Issue 4, p383, 12p
- Subject
RESPIRATORY syncytial virus infections COHORT analysis IMMUNIZATION of children HOSPITAL care RESPIRATORY syncytial virus - Language
- ISSN
- 2076393X